Sionna Therapeutics Stock Forward View - Relative Strength Index
| SION Stock | 37.32 0.64 1.74% |
Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -0.52 | EPS Estimate Current Year -2.21 | EPS Estimate Next Year -2.58 | Wall Street Target Price 49.1111 | EPS Estimate Current Quarter -0.54 |
The hype view outlines Sionna Therapeutics' attention response alongside peer coverage.
Sionna Therapeutics after-hype prediction price | $ 37.49 |
The sentiment summary complements forecasting and technical views with analyst estimates and earnings data.
Cross-verify projections for Sionna Therapeutics using Historical Fundamental Analysis of Sionna Therapeutics. The analysis adds historical context for the projection set.Sionna Therapeutics Additional Predictive Modules
Most predictive techniques to examine Sionna price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sionna using various technical indicators. When you analyze Sionna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Sionna Therapeutics Volatility | Backtest Sionna Therapeutics | Information Ratio |
Sionna Therapeutics Trading Date Momentum
| On March 13 2026 Sionna Therapeutics Common was traded for 37.32 at the closing time. The top price for the day was 37.95 and the lowest listed price was 36.21 . The trading volume for the day was 320.3 K. The trading history from March 13, 2026 did not result in any price rise and fall. The trading price change against the current closing price is -1.71% . |
| Compare Sionna Therapeutics to competition |
Other Forecasting Options for Sionna Therapeutics
Investors at all stages of experience who consider Sionna must develop an understanding of Sionna Therapeutics' price dynamics. The noise embedded in Sionna Stock price charts can create misleading signals and skew investment decisions.Sionna Therapeutics Related Equities
The following equities are related to Sionna Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Sionna Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Sionna Therapeutics Market Strength Events
Market strength indicators applied to Sionna Therapeutics stock give investors a structured view of the security's momentum relative to the overall market. Using these indicators, traders can refine their timing when entering or exiting positions in Sionna Therapeutics Common.
| Accumulation Distribution | 14687.57 | |||
| Daily Balance Of Power | 0.3678 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 37.08 | |||
| Day Typical Price | 37.16 | |||
| Price Action Indicator | 0.56 | |||
| Period Momentum Indicator | 0.64 |
Sionna Therapeutics Risk Indicators
Evaluating Sionna Therapeutics' risk indicators is an important step in accurately forecasting its price and assessing the suitability of an investment. Understanding the risk profile of Sionna Therapeutics' allows investors to make more informed decisions about position sizing and risk.
| Mean Deviation | 3.18 | |||
| Standard Deviation | 4.78 | |||
| Variance | 22.87 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Sionna Therapeutics
Coverage intensity for Sionna Therapeutics Common matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Sionna Therapeutics Short Properties
Short sentiment tied to Sionna Therapeutics Common matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 40 M | |
| Cash And Short Term Investments | 235.9 M |
More Resources for Sionna Stock Analysis
A comprehensive view of Sionna Therapeutics starts with financial statements and ratio context. Ratios and trend metrics help frame Sionna Therapeutics' operating context. Highlighted below are reports that provide context for Sionna Therapeutics Common Stock:Cross-verify projections for Sionna Therapeutics using Historical Fundamental Analysis of Sionna Therapeutics. The analysis adds historical context for the projection set. Analysis related to Sionna Therapeutics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Understanding Sionna Therapeutics includes distinguishing between market value and book value, where book value reflects Sionna's accounting equity. Sionna Therapeutics' market capitalization is 1.65 B. With a P/B ratio of 5.37, the market values Sionna Therapeutics well above its book equity. Enterprise value stands at 1.42 B. Value and price for Sionna Therapeutics are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
The concept of value for Sionna Therapeutics differs from its quoted price, since each reflects a different lens. For Sionna Therapeutics, key inputs include a P/B ratio of 5.37, and ROE of -31.79%. Market price reflects the current exchange level formed by active bids and offers.